Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Yurina Sugita , Tetsuro Miyazaki , Kazunori Shimada , et al Added: 3 years ago
Topic: Preventive Medicine Background Delirium frequently occurs in patients admitted to the intensive care unit and is associated with mortality and morbidity. Although several studies reported associations between polyunsaturated fatty acids (PUFAs) and cognitive disorders, the association between PUFAs and delirium in patients with acute cardiovascular disease remains unknown. Methods and… View more

Prevention & Chronic Conditions
Author(s): Ricardo A Perez de la Hoz , Sandra Patricia Swieszkowski , Federico Matias Cintora , et al Added: 3 years ago
The aim of reviewing the neuroendocrine–humoral response in acute coronary syndrome (ACS) is based on the fact that beyond the distinctive thrombotic event that defines acute occlusion of a coronary artery, generically referred to as a plaque accident, it is not an isolated event. It is clear that a series of physiological and physiopathological mechanisms related to stress – before, during and… View more

Prevention & Chronic Conditions

MI/ACS
Inflammation and Cardiovascular Disease: The Future
Author(s): Natalie Arnold , Katharina Lechner , Christoph Waldeyer , et al Added: 2 years ago

Prevention & Chronic Conditions
Author(s): Heather Currie , Christine Williams Added: 3 years ago
Cardiovascular disease (CVD) is the leading cause of death in both men and women, yet the extent of the problem in women is frequently underestimated and, compared with men, women are less likely to be offered interventions, are less likely to be represented in clinical trials and have a worse prognosis. This article aims to examine the extent of the problem of CVD in women, summarise the… View more

Demographic

Prevention & Chronic Conditions
Cardiac Troponins in Kidney Disease
Author(s): Debasish Banerjee , Charlotte Perrett , Anita Banerjee Added: 3 years ago
The development of increasingly sensitive and specific serum cardiac biomarkers has led a revolution in the diagnosis and management of acute coronary syndrome (ACS). However, although the troponins now in use are considered highly sensitive cardiac biomarkers in the general population, the interpretation of troponins in patients with acute kidney injury (AKI), chronic kidney disease (CKD) and… View more

Prevention & Chronic Conditions

MI/ACS
Author(s): Claudia Agabiti-Rosei , Anna Paini , Massimo Salvetti Added: 3 years ago
Uric acid (UA) represents the final product of purine metabolism, in humans mainly regulated by the xanthine-oxidoreductase enzyme, which converts hyoxantine to xanthine and xanthine to UA. Dietary factors may influence serum UA (SUA), increasing its levels (meat, seafood, fructose, alcohol and sodium) or decreasing them (coffee and ascorbic acid). In addition, high cellular turnover conditions,… View more

Prevention & Chronic Conditions
Cardiovascular Complications of Chronic Kidney Disease: An Introduction
Author(s): Hilary Warrens , Debasish Banerjee , Charles A Herzog Added: 1 year ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Author(s): Richard Hobbs , Terry McCormack , Claudio Cricelli , et al Added: 3 years ago
The interplay between risk factors, the variable influence of any one risk factor and the tendency for risk factors to cluster make the determination of cardiovascular disease (CVD) risk in apparently healthy individuals more complex1 than assessing any single risk factor in isolation. For example, age factors heavily in a patient’s CVD risk; however, a younger patient with multiple factors may… View more

Prevention & Chronic Conditions
ESC 2020: APOC-III Reduction in Cardiovascular Disease
Author(s): Jean-Claude Tardif Added: 3 years ago
Dr Jean-Claude Tardif (Montreal Heart Institute, Montreal, CA) discusses the effects of Apolipoprotein C-III (ApoC-III) reduction in cardiovascular (CV) disease. The administration of APOCIII-LRX in patients with hypertriglyceridemia and high CV risk was associated with inhibition of ApoC-III and lower levels of triglycerides. Questions: 1. What is the background of this study? 2. What was the… View more

Prevention & Chronic Conditions
Author(s): Tracey Keteepe-Arachi , Sanjay Sharma Added: 3 years ago
Globally, cardiovascular disease (CVD) remains the leading cause of mortality in women. Approximately 2.8 million women have been diagnosed with CVD in the UK.1 For many years, the presence of gender-related differences in presentation, risk factors and outcomes have been recognised. Importantly, these discrepancies in presentation and outcomes between the sexes are often associated with… View more

Demographic